ICODE：国际 COVID-19 血栓形成生物标志物研讨会——新型可溶性生物标志物：循环无细胞核酸和其他分子。
ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules.
机构信息
Cardiology and Angiology I, Heart Center, University of Freiburg, Freiburg, Germany.
Medical Intensive Care, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
出版信息
J Thromb Thrombolysis. 2022 Jan;53(1):83-87. doi: 10.1007/s11239-021-02468-6. Epub 2021 May 12.
Abstract
This article summarizes the evidence derived from clinical (observational) studies describing novel soluble biomarkers in COVID-19. Our goal was to stimulate further research (preclinical as well as clinical studies) and therefore we discuss potential prognostic value, but also technical details, such as sample preparation. A table provides an overview of the described biomarkers measured in plasma, serum or other (namely bronchoalveolar) fluids.
摘要
本文总结了临床（观察性）研究中描述新型 COVID-19 可溶性生物标志物的证据。我们的目的是激发进一步的研究（临床前和临床研究），因此我们讨论了潜在的预后价值，同时也讨论了技术细节，如样品制备。本文提供了一个表格，概述了在血浆、血清或其他（即支气管肺泡）液体中测量的描述性生物标志物。
相似文献
1
ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules.ICODE：国际 COVID-19 血栓形成生物标志物研讨会——新型可溶性生物标志物：循环无细胞核酸和其他分子。
J Thromb Thrombolysis. 2022 Jan;53(1):83-87. doi: 10.1007/s11239-021-02468-6. Epub 2021 May 12.
2
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19.循环中的线粒体 DNA 是 COVID-19 重症和死亡的早期指标。
JCI Insight. 2021 Feb 22;6(4):143299. doi: 10.1172/jci.insight.143299.
3
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests.国际新冠病毒血栓形成生物标志物研讨会：新冠病毒诊断检测
J Thromb Thrombolysis. 2021 Nov;52(4):992-998. doi: 10.1007/s11239-021-02465-9. Epub 2021 May 22.
4
Relationship between cardiovascular diseases and circulating cell-free nucleic acids in human plasma.人体血浆中循环无细胞核酸与心血管疾病的关系。
Biomark Med. 2018 Aug;12(8):891-905. doi: 10.2217/bmm-2017-0386. Epub 2018 Jul 20.
5
Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19.血浆微生物游离DNA载量与COVID-19患者的死亡率相关。
Respir Res. 2021 Jan 20;22(1):24. doi: 10.1186/s12931-021-01623-0.
6
Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.用于液体活检的生物传感器：循环核酸用于癌症的诊断和治疗
Anal Bioanal Chem. 2016 Oct;408(26):7255-64. doi: 10.1007/s00216-016-9806-3. Epub 2016 Aug 6.
7
Circulating Nucleic Acids in Maternal Plasma and Serum in Pregnancy Complications: Are They Really Useful in Clinical Practice? A Systematic Review.母体血浆和血清中循环核酸在妊娠并发症中的应用：它们在临床实践中真的有用吗？系统评价。
Mol Diagn Ther. 2020 Aug;24(4):409-431. doi: 10.1007/s40291-020-00468-5.
8
Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.循环外泌体非编码 RNA 作为人肝细胞癌的预后生物标志物。
Int J Cancer. 2019 Mar 15;144(6):1444-1452. doi: 10.1002/ijc.31931. Epub 2018 Dec 3.
9
Circulating Donor-derived Cell-free DNA as a Biomarker in Vascularized Composite Allotransplantation?循环供体来源的游离DNA作为血管化复合组织异体移植的生物标志物？
Transplantation. 2020 Mar;104(3):e79-e80. doi: 10.1097/TP.0000000000003000.
10
Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes.循环核酸生物标志物与 2 型糖尿病。
Int J Mol Sci. 2021 Dec 28;23(1):295. doi: 10.3390/ijms23010295.
引用本文的文献
1
The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies.中性粒细胞胞外诱捕网形成和补体激活在新型冠状病毒肺炎相关凝血病中的作用
Biomedicines. 2023 May 5;11(5):1371. doi: 10.3390/biomedicines11051371.
2
Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.衰老相关炎症的循环生物标志物可作为 COVID-19 重症结局的潜在预测指标。
Mech Ageing Dev. 2022 Jun;204:111667. doi: 10.1016/j.mad.2022.111667. Epub 2022 Mar 25.
3
Neutrophil Extracellular Trap-Driven Occlusive Diseases.中性粒细胞胞外诱捕网导致的闭塞性疾病。
Cells. 2021 Aug 26;10(9):2208. doi: 10.3390/cells10092208.
本文引用的文献
1
Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.羧肽酶 B 阻断 COVID-19 患者中性粒细胞体外过敏毒素-中性粒细胞胞外诱捕网轴的激活。
Crit Care. 2021 Feb 8;25(1):51. doi: 10.1186/s13054-021-03482-z.
2
High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.高水平的中性粒细胞胞外诱捕网持续存在于 2019 年冠状病毒病危重症患者的下呼吸道中。
J Infect Dis. 2021 May 20;223(9):1512-1521. doi: 10.1093/infdis/jiab050.
3
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.高迁移率族蛋白B1作为重症新型冠状病毒肺炎的潜在生物标志物和治疗靶点。
Heliyon. 2020 Dec 7;6(12):e05672. doi: 10.1016/j.heliyon.2020.e05672. eCollection 2020 Dec.
4
Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.中性粒细胞激活与血小板激活与 2019 年冠状病毒病血栓并发症的关系。
J Infect Dis. 2021 Mar 29;223(6):933-944. doi: 10.1093/infdis/jiaa756.
5
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.中性粒细胞胞外诱捕网的循环标志物对COVID-19患者具有预后价值。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994. doi: 10.1161/ATVBAHA.120.315267. Epub 2020 Dec 3.
6
Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.血清蛋白质组学分析揭示 2019 年冠状病毒病中免疫调节蛋白颗粒蛋白的特异性上调。
J Infect Dis. 2021 Mar 3;223(5):775-784. doi: 10.1093/infdis/jiaa741.
7
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.一位危重症 COVID-19 患者血清 ACE2 活性急剧升高。
Int J Infect Dis. 2021 Feb;103:412-414. doi: 10.1016/j.ijid.2020.11.184. Epub 2020 Nov 26.
8
Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.急诊科中血清钙卫蛋白对新型冠状病毒肺炎患者的预后预测
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.016. Epub 2020 Nov 17.
9
Neutrophil extracellular traps and thrombosis in COVID-19.新冠病毒肺炎中的中性粒细胞胞外诱捕网与血栓形成
J Thromb Thrombolysis. 2021 Feb;51(2):446-453. doi: 10.1007/s11239-020-02324-z. Epub 2020 Nov 5.
10
Complement activation and endothelial perturbation parallel COVID-19 severity and activity.补体激活和内皮功能紊乱与 COVID-19 的严重程度和活动并行。
J Autoimmun. 2021 Jan;116:102560. doi: 10.1016/j.jaut.2020.102560. Epub 2020 Oct 29.
Zotero 插件